Analogously to what occurs in cancer cells, the expression of TIGAR and PFKFB3 allows for a high glycolytic flux together with increased capacity for DNA synthesis and control ROS levels in activated lymphocytes. This evidence concerns the gene PFKFB3 and cancer.